[EN] PAD4 INHIBITORS AND USE THEREOF [FR] INHIBITEURS DE PAD4 ET LEUR UTILISATION
摘要:
The present disclosure provides a compound represented by structural formula (I0) or a pharmaceutically acceptable salt, or a stereoisomer thereof and their use in, e.g. treating a disease or disorder associated with the PAD4 activity. This disclosure also features compositions containing the same as well as methods of using and making the same.
B(C6F5)3-Catalyzed tandem cyclization/hydrosilylation for the step-economical construction of 1,2,3,4-tetrahydroquinoxalines from readily available starting materials has been developed.
B(C6F5)3催化的串联环化/氢硅烷化反应,可从易得的起始物构建1,2,3,4-四氢喹啉。
Versatile (Pentamethylcyclopentadienyl)rhodium-2,2′-Bipyridine (Cp*Rh-bpy) Catalyst for Transfer Hydrogenation of N-Heterocycles in Water
An investigation employing the catalytic system consisting of (pentamethylcyclopentadienyl)rhodium dichloride dimer [Cp*RhCl2]2 and 2,2′-bipyridine (bpy) for transferhydrogenation of a variety of quinoxalines, quinoxalinones, quinolines and indoles under aqueous conditions with formate as the hydrogen source is reported. This approach provides various tetrahydroquinoxalines, dihydroquinoxalinones
Benzodiazepine And Benzopiperazine Analog Inhibitors Of Histone Deacetylase
申请人:Leit Silvana
公开号:US20070155730A1
公开(公告)日:2007-07-05
This invention relates to compounds for the inhibition of histone deacetylase. More particularly, the invention provides for compounds of formula (I)
wherein A, B, D, E, X
1
, X
2
, X
3
, X
4
and n are as defined in the specification.